33,968 Shares in Core Scientific, Inc. $CORZ Acquired by Helium Advisors LLC

Helium Advisors LLC bought a new stake in shares of Core Scientific, Inc. (NASDAQ:CORZ) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 33,968 shares of the company’s stock, valued at approximately $508,000.

Other large investors have also recently added to or reduced their stakes in the company. Xponance LLC increased its holdings in shares of Core Scientific by 2.5% in the fourth quarter. Xponance LLC now owns 22,896 shares of the company’s stock valued at $333,000 after buying an additional 562 shares in the last quarter. CWA Asset Management Group LLC boosted its stake in shares of Core Scientific by 0.3% during the 4th quarter. CWA Asset Management Group LLC now owns 239,937 shares of the company’s stock worth $3,493,000 after acquiring an additional 756 shares in the last quarter. Orion Porfolio Solutions LLC boosted its stake in shares of Core Scientific by 5.2% during the 3rd quarter. Orion Porfolio Solutions LLC now owns 15,539 shares of the company’s stock worth $279,000 after acquiring an additional 766 shares in the last quarter. Bank of Montreal Can grew its holdings in shares of Core Scientific by 4.2% in the 4th quarter. Bank of Montreal Can now owns 21,592 shares of the company’s stock worth $314,000 after acquiring an additional 869 shares during the last quarter. Finally, Allworth Financial LP grew its holdings in shares of Core Scientific by 206.5% in the 3rd quarter. Allworth Financial LP now owns 1,410 shares of the company’s stock worth $25,000 after acquiring an additional 950 shares during the last quarter.

Core Scientific Stock Performance

Shares of NASDAQ CORZ opened at $21.02 on Friday. The business’s 50-day simple moving average is $25.50 and its 200-day simple moving average is $20.39. Core Scientific, Inc. has a 52 week low of $12.60 and a 52 week high of $30.46. The firm has a market cap of $6.68 billion, a price-to-earnings ratio of -18.44 and a beta of 5.50.

Core Scientific (NASDAQ:CORZ) last issued its quarterly earnings results on Wednesday, May 6th. The company reported ($1.06) EPS for the quarter, missing the consensus estimate of ($0.02) by ($1.04). The business had revenue of $115.24 million during the quarter, compared to the consensus estimate of $117.04 million. During the same quarter in the prior year, the company posted $1.25 earnings per share. The firm’s revenue for the quarter was up 44.9% on a year-over-year basis. As a group, equities research analysts forecast that Core Scientific, Inc. will post 0.08 earnings per share for the current year.

Insider Activity at Core Scientific

In related news, insider Todd M. Duchene sold 10,000 shares of the stock in a transaction dated Monday, July 6th. The shares were sold at an average price of $22.63, for a total value of $226,300.00. Following the completion of the sale, the insider owned 2,023,426 shares in the company, valued at approximately $45,790,130.38. This trade represents a 0.49% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders have sold a total of 90,000 shares of company stock worth $2,209,800 over the last three months. 1.70% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the company. BTIG Research upped their target price on Core Scientific from $33.00 to $38.00 and gave the company a “buy” rating in a report on Wednesday, June 24th. Sanford C. Bernstein reissued an “outperform” rating and issued a $32.00 price target on shares of Core Scientific in a research note on Wednesday, June 3rd. Canaccord Genuity Group set a $30.00 price target on Core Scientific in a research note on Friday, May 8th. B. Riley Financial boosted their price objective on Core Scientific from $30.00 to $33.00 and gave the stock a “buy” rating in a report on Wednesday, May 27th. Finally, Jefferies Financial Group upped their price objective on shares of Core Scientific from $24.00 to $37.00 and gave the company a “buy” rating in a research note on Thursday, May 14th. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $29.78.

Core Scientific Company Profile

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.